Spect Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-07-2024
- Paid Up Capital ₹ 0.60 M
as on 12-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.80 M
as on 12-07-2024
- Revenue 161.51%
(FY 2020)
- Profit -13676.60%
(FY 2020)
- Ebitda 84.33%
(FY 2020)
- Net Worth -73.27%
(FY 2020)
- Total Assets -12.21%
(FY 2020)
About Spect Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹0.80 M.
Arun Kumar and Shisham Sharma serve as directors at the Company.
- CIN/LLPIN
U74999BR2017PTC034167
- Company No.
034167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spect Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kumar  | Director | 30-Mar-2017 | Current |
| Shisham Sharma | Director | 30-Mar-2017 | Current |
Financial Performance of Spect Pharma.
Spect Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 161.51% increase. The company also saw a substantial fall in profitability, with a 13676.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spect Pharma?
In 2018, Spect Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 23 Sep 2021 | ₹0.80 M | Open |
How Many Employees Work at Spect Pharma?
Unlock and access historical data on people associated with Spect Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spect Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spect Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
